Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of binding and different CB1 receptor activation assays. Part III: The G protein pathway and critical comparison of different assays-Reference-Cited by-同舟云学术

Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of binding and different CB1 receptor activation assays. Part III: The G protein pathway and critical comparison of different assays

Published:2021-05-21 Issue:7 Volume:13 Page:1412-1429
ISSN:1942-7603
Container-title:Drug Testing and Analysis
language:en
Short-container-title:Drug Test Anal

Author:

Grafinger Katharina Elisabeth¹²^ORCID,Vandeputte Marthe M.²^ORCID,Cannaert Annelies²^ORCID,Ametovski Adam³⁴,Sparkes Eric³⁴,Cairns Elizabeth³,Juchli Patrick Osamu⁵,Haschimi Belal¹⁶^ORCID,Pulver Benedikt¹⁶^ORCID,Banister Samuel D.³⁴^ORCID,Stove Christophe P.²^ORCID,Auwärter Volker¹^ORCID

Affiliation:

1. Institute of Forensic Medicine, Forensic Toxicology, Medical Center – University of Freiburg, Faculty of Medicine University of Freiburg Freiburg Germany

2. Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences Ghent University Ghent Belgium

3. The Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre The University of Sydney Camperdown NSW Australia

4. School of Chemistry The University of Sydney Sydney NSW Australia

5. Data & Analytics PwC Switzerland Zürich Switzerland

6. Hermann Staudinger Graduate School University of Freiburg Freiburg Germany

Funder

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Fonds Wetenschappelijk Onderzoek

National Health and Medical Research Council

Publisher

Wiley

Subject

Spectroscopy,Pharmaceutical Science,Environmental Chemistry,Analytical Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/dta.3054

Reference66 articles.

1. EMCDDA.European Drug Report 2020: Trends and Developments.2020.https://www.emcdda.europa.eu/publications/edr/trends-developments/2020_enhttps://doi.org/10.2810/420678

2. UNODC.Current NPS Threats‐ Volume III.2020;III:6.https://www.unodc.org/documents/scientific/Current_NPS_Threats_Vol.3.pdf

3. UNODC.Current NPS Threats‐ Volume II.2020;II:6.https://www.unodc.org/documents/scientific/Current_NPS_Threats_Volume_II_Web.pdf

4. Pharmacology and stereoselectivity of structurally novel cannabinoids in mice;Little PJ;J Pharmacol Exp Ther,1988

5. Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from Δ9‐tetrahydrocannabinol;Compton DR;J Pharmacol Exp Ther,1992

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interpreting mono- and poly-SCRA intoxications from an activity-based point of view: JWH-018 equivalents in serum as a comparative measure;Archives of Toxicology;2024-08-08

2. Structure–Activity Relationships, Deuteration, and Fluorination of Synthetic Cannabinoid Receptor Agonists Related to AKB48, 5F-AKB-48, and AFUBIATA;ACS Chemical Neuroscience;2024-05-20

3. Synthesis and Functional Evaluation of Synthetic Cannabinoid Receptor Agonists Related to ADB-HEXINACA;ACS Chemical Neuroscience;2024-04-10

4. Investigating selectivity and bias for G protein subtypes and β-arrestins by synthetic cannabinoid receptor agonists at the cannabinoid CB1 receptor;Biochemical Pharmacology;2024-04

5. Differential cannabinoid‐like effects and pharmacokinetics of ADB‐BICA, ADB‐BINACA, ADB‐4en‐PINACA and MDMB‐4en‐PINACA in mice: A comparative study;Addiction Biology;2024-02